
Keyxone S 250mg/125mg Injection
Marketer
Geologic Labs Pvt. Ltd.
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Keyxone S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), marketed as Keyxone S, combats bacterial infections by inhibiting microbial growth. This combination medication requires administration by a healthcare professional. Complete the prescribed course, even with symptom improvement, as premature cessation may reduce effectiveness. Regularly scheduled doses are crucial. Possible side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, itching, swelling, breathing difficulties). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally driving ability is unaffected, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and hydration support recovery. Monitoring may include laboratory tests to assess treatment efficacy.
Primary Ingredients of Keyxone S 250mg/125mg Injection
No text provided to rephrase.
Uses of Keyxone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Keyxone S 250mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Keyxone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Keyxone S 250mg/125mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Keyxone S 250mg/125mg Injection works:
Keyxone S injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action mechanism. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Keyxone S 250mg/125mg Injection shows no adverse reactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Keyxone S (250mg/125mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Keyxone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Keyxone S 250mg/125mg Injection might reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Keyxone S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Keyxone S 250mg/125mg Injection cautiously, potentially requiring dose modification. A physician's consultation is advised. Dose alteration for Keyxone S 250mg/125mg Injection is unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Keyxone S 250mg/125mg Injection :
Should you forget a scheduled Keyxone S 250mg/125mg Injection, seek medical advice.
Facts to Know About Keyxone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
